BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
20.30
-0.08 (-0.39%)
Mar 6, 2026, 3:53 PM EST - Market open
BioAge Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 26.95 | 19.16 | 14.51 | 9.45 |
| Research & Development | 59.04 | 59.04 | 33.89 | 30.52 |
| Operating Expenses | 85.98 | 78.19 | 48.4 | 39.97 |
| Operating Income | -89.72 | -78.19 | -48.4 | -39.97 |
| Interest Expense | -0.92 | -2.37 | -7.79 | -0.24 |
| Interest & Investment Income | 14.39 | 9.63 | 2.43 | 0.47 |
| EBT Excluding Unusual Items | -75.86 | -70.93 | -53.76 | -39.75 |
| Other Unusual Items | 0.07 | -0.18 | -10.09 | 0.02 |
| Pretax Income | -75.79 | -71.11 | -63.85 | -39.72 |
| Net Income | -75.79 | -71.11 | -63.85 | -39.72 |
| Net Income to Common | -75.79 | -71.11 | -63.85 | -39.72 |
| Shares Outstanding (Basic) | 36 | 11 | 2 | 2 |
| Shares Outstanding (Diluted) | 36 | 11 | 2 | 2 |
| Shares Change (YoY) | 1576.12% | 541.23% | 0.06% | - |
| EPS (Basic) | -2.11 | -6.63 | -38.17 | -23.76 |
| EPS (Diluted) | -2.11 | -6.63 | -38.17 | -23.76 |
| Free Cash Flow | -59.15 | -51.89 | -37.53 | -36.28 |
| Free Cash Flow Per Share | -1.65 | -4.84 | -22.43 | -21.70 |
| EBITDA | -89.53 | -78.03 | -48.24 | -39.84 |
| D&A For EBITDA | 0.19 | 0.17 | 0.16 | 0.13 |
| EBIT | -89.72 | -78.19 | -48.4 | -39.97 |
Source: S&P Capital IQ. Standard template.
Financial Sources.